Search results
Opinion | Swift drug approvals the right medicine for Hong Kong
South China Morning Post· 43 minutes agoPharmaceutical firms may submit applications to the Hospital Authority directly without going through doctors under the measures, which will be ready in half a year. Pharmaceutical companies ...
Senators place blame for sky-high drug prices on abuse of the patent system
NBC News via Yahoo News· 21 minutes agoThe drug industry’s top lobbying group faced fierce questioning at a Senate Judiciary Committee...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters via Yahoo Finance· 15 hours agoNovo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the company saw...
The evidence suggests the DEA still has not come around on rescheduling marijuana
Reason.com· 38 minutes agoIn that case, the DEA reiterated its long-standing position that removing marijuana from Schedule I,...
Wegovy, Saxenda study reveals surprising trend for weight loss drugs
USA Today· 13 hours agoMore than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended...
...Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide Why Is Eli Lilly Stock...
Benzinga· 10 hours agoOn Tuesday, Eli Lilly And Company LLY announced that Chinese regulators have approved its diabetes ...
Canaccord cuts Aptose Biosciences shares target, expects lead drug approval delay By Investing.com
Investing.com· 6 days agoOn Thursday, Canaccord Genuity (TSX:CF) adjusted its price target on Aptose Biosciences...
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 5 hours agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
GSK says its experimental drug reduced asthma attacks with only two doses a year
Quartz· 2 hours agoPeople suffering from a severe form of asthma could soon see their symptoms improve with a new...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 11 hours agoDepemokimab could be the first approved drug to allow a long-term dosing interval, requiring only...